182 related articles for article (PubMed ID: 35710947)
41. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
42. Knockdown of lncRNA TUG1 suppresses corneal angiogenesis through regulating miR-505-3p/VEGFA.
Liu S; Gao J; Chen J
Microvasc Res; 2021 Nov; 138():104233. PubMed ID: 34411571
[TBL] [Abstract][Full Text] [Related]
43. Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer.
Le K; Guo H; Zhang Q; Huang X; Xu M; Huang Z; Yi P
Sci Rep; 2019 Oct; 9(1):15122. PubMed ID: 31641220
[TBL] [Abstract][Full Text] [Related]
44. LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production.
Nafea H; Youness RA; Abou-Aisha K; Gad MZ
J Cell Physiol; 2021 Jul; 236(7):5362-5372. PubMed ID: 33368266
[TBL] [Abstract][Full Text] [Related]
45. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways.
Liu Z; Guo N; Zhang XJ
Microvasc Res; 2022 Jan; 139():104231. PubMed ID: 34352236
[TBL] [Abstract][Full Text] [Related]
46. LncRNA XIST interacts with miR-454 to inhibit cells proliferation, epithelial mesenchymal transition and induces apoptosis in triple-negative breast cancer.
Li X; Hou L; Yin L; Zhao S
J Biosci; 2020; 45():. PubMed ID: 32098924
[TBL] [Abstract][Full Text] [Related]
47. Circular RNA hsa_circ_0131242 Promotes Triple-Negative Breast Cancer Progression by Sponging hsa-miR-2682.
Li Y; Shi P; Zheng T; Ying Z; Jiang D
Onco Targets Ther; 2020; 13():4791-4798. PubMed ID: 32547106
[TBL] [Abstract][Full Text] [Related]
48. Knockdown of long non-coding RNA HOST2 inhibits the proliferation of triple negative breast cancer via regulation of the let-7b/CDK6 axis.
Zhang Y; Zhang H; Kang H; Huo W; Zhou Y; Zhang Y
Int J Mol Med; 2019 Feb; 43(2):1049-1057. PubMed ID: 30483747
[TBL] [Abstract][Full Text] [Related]
49. Upregulation of circ-UBAP2 predicts poor prognosis and promotes triple-negative breast cancer progression through the miR-661/MTA1 pathway.
Wang S; Li Q; Wang Y; Li X; Wang R; Kang Y; Xue X; Meng R; Wei Q; Feng X
Biochem Biophys Res Commun; 2018 Nov; 505(4):996-1002. PubMed ID: 30314706
[TBL] [Abstract][Full Text] [Related]
50. Circ_0001178 regulates miR-382/VEGFA axis to facilitate hepatocellular carcinoma progression.
Gao S; Hu W; Huang X; Huang X; Chen W; Hao L; Chen Z; Wang J; Wei H
Cell Signal; 2020 Aug; 72():109621. PubMed ID: 32240747
[TBL] [Abstract][Full Text] [Related]
51. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
Han C; Fu Y; Zeng N; Yin J; Li Q
Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
[TBL] [Abstract][Full Text] [Related]
52. LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702.
Mou E; Wang H
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31399501
[TBL] [Abstract][Full Text] [Related]
53. lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6.
Eades G; Wolfson B; Zhang Y; Li Q; Yao Y; Zhou Q
Mol Cancer Res; 2015 Feb; 13(2):330-8. PubMed ID: 25253741
[TBL] [Abstract][Full Text] [Related]
54. Long noncoding RNA (lncRNA) metallothionein 1 J, pseudogene (MT1JP) is downregulated in triple-negative breast cancer and upregulates microRNA-138 (miR-138) to downregulate hypoxia-inducible factor-1α (HIF-1α).
Wang G; Dong Y; Liu H; Ji N; Cao J; Liu A; Tang X; Ren Y
Bioengineered; 2022 May; 13(5):13718-13727. PubMed ID: 35703312
[TBL] [Abstract][Full Text] [Related]
55. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
[TBL] [Abstract][Full Text] [Related]
56. USP6NL mediated by LINC00689/miR-142-3p promotes the development of triple-negative breast cancer.
Ma T; Liu H; Liu Y; Liu T; Wang H; Qiao F; Song L; Zhang L
BMC Cancer; 2020 Oct; 20(1):998. PubMed ID: 33054738
[TBL] [Abstract][Full Text] [Related]
57. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression.
Fan H; Yuan J; Li X; Ma Y; Wang X; Xu B; Li X
Biomed Pharmacother; 2020 May; 125():109987. PubMed ID: 32058222
[TBL] [Abstract][Full Text] [Related]
58. Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin-proteasomal degradation of COX-2.
Pan T; Zhou D; Shi Z; Qiu Y; Zhou G; Liu J; Yang Q; Cao L; Zhang J
Cancer Lett; 2020 Jul; 482():102-111. PubMed ID: 31705927
[TBL] [Abstract][Full Text] [Related]
59. Alternative splicing of VEGFA is regulated by RBM10 in endometrial cancer.
Dou XQ; Chen XJ; Wen MX; Zhang SZ; Zhou Q; Zhang SQ
Kaohsiung J Med Sci; 2020 Jan; 36(1):13-19. PubMed ID: 31587503
[TBL] [Abstract][Full Text] [Related]
60. LncRNA TNK2-AS1 regulated ox-LDL-stimulated HASMC proliferation and migration via modulating VEGFA and FGF1 expression by sponging miR-150-5p.
Cai T; Cui X; Zhang K; Zhang A; Liu B; Mu JJ
J Cell Mol Med; 2019 Nov; 23(11):7289-7298. PubMed ID: 31468685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
